agonists in heart failure and chronic kidney disease (CKD) patients was discussed. GLP-1R agonists are cardioprotective ...
Twin sisters living with heart failure are calling for an end to what they say is a postcode lottery when it comes to ...
In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...
A new study by researchers at Intermountain Health in Salt Lake City finds that 40 percent of newly diagnosed heart failure patients also have atrial fibrillation – a combination of cardiac ...
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...
A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...
Heart failure sounds scary - because it is. But here's the thing: millions of Americans are walking around right now with a ...
Of the 518 hospitals that had at least 10 eligible discharges, only 11 of them prescribed SGLT2 inhibitors to more than half ...
Researchers have found a potential method to slow heart failure progression. They fed mice a diet high in soybean protein, which influenced gut bacteria and supported heart health. Analysis showed ...
Eli Lilly's tirzepatide cut cardiovascular mortality and heart failure event risk by 38% in HFpEF patients over a ...
The FINEARTS-HF trial offered novel clinical insights as one of the few cardiovascular trials to feature such a great proportion of female participants.
Ten hours or more of sedentary behaviour per day may increase heart failure risk even in those who regularly exercise, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback